Two Labs Blog

Two Labs Blog

Rich Wartel

Find me on:

Recent Posts

Two Labs Acquires MKO Global Partners

Posted by Rich Wartel on February 8, 2018

At Two Labs, we’re committed to staying at the forefront of the evolving healthcare market -- and to support our growth goals, we believe it’s invaluable to add insightful team members who have their own valuable perspectives.

Screen Shot 2017-08-04 at 9.08.43 AM-1.png

Today, we are pleased to share that as of February 2, 2018, Two Labs has acquired MKO Global Partners (MKO), a strategic global life sciences consulting firm focused on payer strategy, market access, and pricing in the pharmaceutical and biotech markets.

The union of Two Labs and MKO’s pharma services expands our total solution suite for market access, allowing us to provide many new services and areas of expertise. By combining our capabilities with MKO’s, we’re now able to guide clients on how to address value proposition concerns within the payer market, emphasizing all aspects of product pricing and payer segmentation.

Culture stands at the core of everything we do, and MKO exemplifies everything we look for in a partner. Their team is performance-driven and embraces the entrepreneurial mindset, seeking new opportunities for innovation and value creation. Most importantly, they have a passion for creating patient access through the products that they represent, highlighting the strong values alignment between our two organizations. Our principals have worked with and known the MKO principals for over 15 years, and they’ve exceeded our expectations for a partner with the same desire to grow and emphasis on culture. Each organization views the other as the logical extension toward the total solutions suite for pharmaceutical, biotech, and life sciences consulting solutions – and we believe our clients will be thrilled with the capabilities available through a single source.

Going forward our goals and commitment to the patient will remain unchanged: helping them better gain access to necessary pharma products. The pharma market is growing rapidly, and this acquisition will provide the support needed as we further invest in the expansion of our services to meet our clients’ evolving needs.

We are excited to welcome MKO, and look forward the impact their skills and expertise will have on Two Labs and the commercialization process.

Topics: Two Labs

Subscribe to Email Updates

Recent Posts